EQRx Investor Relations Material

EQRx, Inc. is a biotechnology company focused on developing and delivering innovative medicines at more affordable prices. The company aims to address the high cost of drugs by re-engineering the drug discovery and development process, creating therapies for conditions such as cancer and immune-inflammatory diseases. EQRx seeks to offer high-quality treatments that are more accessible to healthcare systems and patients. The company collaborates with global partners to advance its drug pipeline while leveraging advanced technologies to expedite drug development and reduce costs. The company is headquartered in Cambridge, Massachusetts, and its shares are listed on the NASDAQ.